ARQ 087 had manageable toxicity at the RP2D of 300 mg QD, showed pharmacodynamics effects, and achieved objective responses, notably in patients with FGFR2 genetic alterations.
No takes yet. Share an insight, caveat, or question.
Papadopoulos et al. (2017) studied this question.